Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial
Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial have?
Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial has 31 citations in the OpenAlex counts ScholarIQ stores.
When was Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial published?
Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial has 2023 year in the ScholarIQ index.
What is the open-access status of Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial?
Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial has closed oa status in the ScholarIQ index.
What is the DOI of Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial?
The DOI for Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial is on the source record.
What is the PMID of Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial?
The PMID for Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial is on the source record.
What is the OpenAlex record for Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial?
The OpenAlex for Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial is on the source record.